Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells
- PMID: 29555554
- DOI: 10.1016/j.jmb.2018.03.008
Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells
Abstract
Activation of estrogen receptor α (ERα) stimulates cell division and tumor growth by modulating the expression of ERα target genes. This activation involves the recruitment of specific proteins with activities that are still not fully understood. Timeless, the human homolog of the Drosophila gene involved in circadian rhythm, was previously shown to be a strong predictor of tamoxifen relapse, and is involved in genomic stability and cell cycle control. In this study, we investigated the interplay between Timeless and ERα, and showed that human Timeless is an ERα coactivator. Timeless binds to ERα and enhances its transcriptional activity. Overexpressing Timeless increases PARP1 expression and enhances ERα-induced gene regulation through the proximal LXXLL motif on Timeless protein and ERα PARylation. Finally, Timeless is recruited with ERα on the GREB1 and cMyc promoters. These data, the first to link Timeless to steroid hormone function, provide a mechanistic basis for its clinical association with tamoxifen resistance. Thus, our results identify Timeless as another key regulator of ERα in controlling ERα transactivation.
Keywords: breast cancer; coactivator; estrogen receptor; tamoxifen.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
PARP-1 as a novel target in endocrine-resistant breast cancer.J Exp Clin Cancer Res. 2025 Jun 16;44(1):175. doi: 10.1186/s13046-025-03441-4. J Exp Clin Cancer Res. 2025. PMID: 40518539 Free PMC article.
-
Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.J Cell Physiol. 2012 Oct;227(10):3363-72. doi: 10.1002/jcp.24035. J Cell Physiol. 2012. PMID: 22213398
-
RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).J Cancer Res Clin Oncol. 2013 Dec;139(12):2079-88. doi: 10.1007/s00432-013-1533-y. Epub 2013 Oct 6. J Cancer Res Clin Oncol. 2013. PMID: 24096540 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Cochrane Database Syst Rev. 2009. PMID: 19821328 Free PMC article.
Cited by
-
The TIMELESS effort for timely DNA replication and protection.Cell Mol Life Sci. 2023 Mar 9;80(4):84. doi: 10.1007/s00018-023-04738-3. Cell Mol Life Sci. 2023. PMID: 36892674 Free PMC article. Review.
-
Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer.Mol Ther. 2020 Jan 8;28(1):313-327. doi: 10.1016/j.ymthe.2019.08.015. Epub 2019 Sep 3. Mol Ther. 2020. PMID: 31604679 Free PMC article.
-
Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin.Cancers (Basel). 2019 Jul 19;11(7):1011. doi: 10.3390/cancers11071011. Cancers (Basel). 2019. PMID: 31331001 Free PMC article.
-
Nuclear Receptor Coregulators in Hormone-Dependent Cancers.Cancers (Basel). 2022 May 13;14(10):2402. doi: 10.3390/cancers14102402. Cancers (Basel). 2022. PMID: 35626007 Free PMC article. Review.
-
A Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity.Cancers (Basel). 2021 Mar 30;13(7):1583. doi: 10.3390/cancers13071583. Cancers (Basel). 2021. PMID: 33808099 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous